FENNEC PHARMACEUTICALS INC. Derivative Liability
FENNEC PHARMACEUTICALS INC. (FENC) had Derivative Liability of $0 as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2020-05-14
- 2020-03-31: Derivative Liability $0.00.
- 2019-12-31: Derivative Liability $0.00.
- 2019-09-30: Derivative Liability $0.00.
- 2019-06-30: Derivative Liability $0.00.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $0.00 10-Q · filed 2020-05-14 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $167.00K 10-K · filed 2019-03-15 | |
| 2017-03-31 | $71.00K 10-Q · filed 2018-05-14 | |
| 2016-12-31 | $33.00K 10-K · filed 2018-03-28 | |
| 2016-03-31 | $39.00K 10-Q · filed 2017-05-12 | |
| 2015-12-31 | $82.00K 10-K · filed 2017-03-29 | |
| 2015-09-30 | $93.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $309.00K 10-Q · filed 2015-11-12 | |
| 2015-03-31 | $694.00K 10-Q · filed 2016-05-12 | |
| 2014-12-31 | $1.32M 10-K · filed 2016-03-28 | |
| 2014-09-30 | $3.50M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $5.34M 10-Q · filed 2015-08-11 | |
| 2014-03-31 | $5.52M 10-Q · filed 2015-05-15 | $116.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $54.00K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |